Skip to content

Observation on the efficacy of transcutaneous electrical acupoint stimulation in treating hypertension-induced headache of liver-yang hyperactivity type

Observation on the efficacy of transcutaneous electrical acupoint stimulation in treating hypertension-induced headache of liver-yang hyperactivity type

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001599
Enrollment
Unknown
Registered
2025-08-21
Start date
2025-09-01
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypertension-induced headache

Interventions

Conventional drug group:Conventional drug

Sponsors

Shanghai Seventh People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged 30-75, with no gender restrictions; 2. Diagnosed with essential hypertension; 3. Headache VAS score = 4; 4. The patient or their family members are willing to undergo treatment, actively cooperate, and voluntarily sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Secondary hypertension (renal artery stenosis pheochromocytoma etc.); 2. Migraine tension headache or other primary headaches; 3. Severe heart brain or kidney diseases (e.g. NYHA heart function class III-IV eGFR <30mL/min etc.) or cerebrovascular accidents; 4. Skin damage allergic constitution or allergy to electrode patch materials; 5.Patients with cardiac pacemakers or other metal components who are unable to undergo electrical stimulation; 6. Women who are pregnant or breastfeeding. 7. Patients with cognitive impairment or severe mental illness. 8. Patients who are concurrently or currently participating in other clinical studies.

Design outcomes

Primary

MeasureTime frame
VAS score;

Secondary

MeasureTime frame
SAS score;renin;aldosterone;24-hour ambulatory blood pressure monitoring;BPI score;TCM symptom score; Daily basic blood pressure;SF-36 score;Angiotensin;

Countries

China

Contacts

Public ContactPang Jiadong

Shanghai Seventh People's Hospital

danny9187@163.com18017690417

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026